Can Peptide Therapies Mitigate Long-Term Cardiovascular Risks Associated with Metabolic Syndrome?
Peptide therapies and hormonal optimization can mitigate cardiovascular risks by recalibrating metabolic function and reducing systemic inflammation.
HRTioJuly 25, 2025